284 related articles for article (PubMed ID: 26307429)
81. [The biomarkers of cerebral ischemia as a new method for the validation of the efficacy of cytoprotective therapy].
Dambinova SA; Aliev KT; Bondarenko EV; Ponomarev GV; Skoromets AA; Skoromets AP; Skoromets TA; Smolko DG; Shumilina MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):62-67. PubMed ID: 28638033
[TBL] [Abstract][Full Text] [Related]
82. Enhanced in vivo platelet activation in subtypes of ischemic stroke.
Shah AB; Beamer N; Coull BM
Stroke; 1985; 16(4):643-7. PubMed ID: 3161220
[TBL] [Abstract][Full Text] [Related]
83. C-Reactive Protein Predicts Further Ischemic Events in Patients With Transient Ischemic Attack or Lacunar Stroke.
Mengozzi M; Kirkham FA; Girdwood EER; Bunting E; Drazich E; Timeyin J; Ghezzi P; Rajkumar C
Front Immunol; 2020; 11():1403. PubMed ID: 32733466
[TBL] [Abstract][Full Text] [Related]
84. Ischemic transient neurological events identified by immune response to cerebral ischemia.
Jickling GC; Zhan X; Stamova B; Ander BP; Tian Y; Liu D; Sison SM; Verro P; Johnston SC; Sharp FR
Stroke; 2012 Apr; 43(4):1006-12. PubMed ID: 22308247
[TBL] [Abstract][Full Text] [Related]
85. Blood biomarkers in the early stage of cerebral ischemia.
Maestrini I; Ducroquet A; Moulin S; Leys D; Cordonnier C; Bordet R
Rev Neurol (Paris); 2016 Mar; 172(3):198-219. PubMed ID: 26988891
[TBL] [Abstract][Full Text] [Related]
86. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
87. Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack.
Dong X; Nao J
Neurotox Res; 2019 Nov; 36(4):645-652. PubMed ID: 31267489
[No Abstract] [Full Text] [Related]
88. Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects.
Chen L; Gu H; Li J; Yang ZY; Sun X; Zhang L; Shan L; Wu L; Wei X; Zhao Y; Ma W; Zhang H; Cao S; Huang T; Miao J; Yuan Z
Sci Rep; 2016 Jan; 6():19248. PubMed ID: 26750556
[TBL] [Abstract][Full Text] [Related]
89. The Importance of the Full Blood Count in Cerebral Ischemia: A Review of 609 Consecutive Young Patients with Stroke and Transient Ischemic Attacks.
Taylor A; Alakbarzade V; Chandratheva A; Simister R; Scully M
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2500-2504. PubMed ID: 29983229
[TBL] [Abstract][Full Text] [Related]
90. Blood-Brain Barrier Leakage: A New Biomarker in Transient Ischemic Attacks.
Serlin Y; Ofer J; Ben-Arie G; Veksler R; Ifergane G; Shelef I; Minuk J; Horev A; Friedman A
Stroke; 2019 May; 50(5):1266-1269. PubMed ID: 31009340
[TBL] [Abstract][Full Text] [Related]
91. Identification of Serum Biomarkers for Ischemic Penumbra by iTRAQ-Based Quantitative Proteomics Analysis.
Pang XM; Zhou X; Su SY; Chen CY; Wei ZX; Tao YF; Liu JL
Proteomics Clin Appl; 2019 Sep; 13(5):e1900009. PubMed ID: 31099185
[TBL] [Abstract][Full Text] [Related]
92. Platelet aggregation, stroke, and transient ischemic attack in middle-aged and elderly patients.
Couch JR; Hassanein RS
Neurology; 1976 Sep; 26(9):888-95. PubMed ID: 986032
[TBL] [Abstract][Full Text] [Related]
93. Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
Ngo D; Sinha S; Shen D; Kuhn EW; Keyes MJ; Shi X; Benson MD; O'Sullivan JF; Keshishian H; Farrell LA; Fifer MA; Vasan RS; Sabatine MS; Larson MG; Carr SA; Wang TJ; Gerszten RE
Circulation; 2016 Jul; 134(4):270-85. PubMed ID: 27444932
[TBL] [Abstract][Full Text] [Related]
94. Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in the Chinese population.
Tu WJ; Liu XY; Dong H; Yu Y; Wang Y; Chen H
J Mol Neurosci; 2014 Apr; 52(4):507-14. PubMed ID: 24352714
[TBL] [Abstract][Full Text] [Related]
95. Stroke is related to lower serum thyrotropin levels in patients with diabetes mellitus.
Seghieri G; Bardini G; Fascetti S; Moruzzo D; Franconi F
Diabetes Res Clin Pract; 2003 Dec; 62(3):203-9. PubMed ID: 14625135
[TBL] [Abstract][Full Text] [Related]
96. Serum protein biomarkers screening in patients with ischemic stroke by LC-MS/MS.
Wei XJ; Li F; Yang FY; Duan CH
Int J Neurosci; 2016 Aug; 126(8):692-9. PubMed ID: 26000912
[TBL] [Abstract][Full Text] [Related]
97. Transient ischemic attacks characterized by RNA profiles in blood.
Zhan X; Jickling GC; Tian Y; Stamova B; Xu H; Ander BP; Turner RJ; Mesias M; Verro P; Bushnell C; Johnston SC; Sharp FR
Neurology; 2011 Nov; 77(19):1718-24. PubMed ID: 21998319
[TBL] [Abstract][Full Text] [Related]
98. Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review.
Nicolaou O; Kousios A; Hadjisavvas A; Lauwerys B; Sokratous K; Kyriacou K
J Cell Mol Med; 2017 May; 21(5):993-1012. PubMed ID: 27878954
[TBL] [Abstract][Full Text] [Related]
99. Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.
Bălănescu P; Lădaru A; Bălănescu E; Băicuş C; Dan GA
Biomarkers; 2014 Aug; 19(5):345-55. PubMed ID: 24831309
[TBL] [Abstract][Full Text] [Related]
100. Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression.
Liu P; Li R; Antonov AA; Wang L; Li W; Hua Y; Guo H; Wang L; Liu P; Chen L; Tian Y; Xu F; Zhang Z; Zhu Y; Huang Y
J Proteome Res; 2017 Feb; 16(2):773-779. PubMed ID: 28092160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
